Literature DB >> 8176682

Western blot and indirect fluorescent antibody testing for antibodies reactive with Ehrlichia canis in sera from apparently healthy dogs in Zimbabwe.

L A Matthewman1, P J Kelly, S M Mahan, D Semu, M Tagwira, P A Bobade, P Brouqui, P R Mason, D Raoult.   

Abstract

Sera were collected from apparently healthy dogs in 3 major centres in Zimbabwe to establish the prevalence of antibodies reactive with Ehrlichia canis by indirect fluorescent antibody (IFA) testing at titres of 1/20 or greater. The overall seroprevalence was 42% (39/93) with dogs from Mutare (40%) and Harare (33%) having similar rates which were lower than those for Bulawayo (68%). The majority of the IFA positive dogs from Harare (67%) had no haematological or biochemical evidence of canine ehrlichiosis. Total protein, albumin and globulin values were determined in sera from blood collected from Bulawayo and Mutare and all values were within normal reference ranges. Western blot profiles of sera from dogs with IFA titres of greater than 1/160 were similar to those using sera from dogs experimentally infected with E. canis Oklahoma strain. Our results indicate that an organism which is antigenically very similar or identical to E. canis is present in Zimbabwe and that dogs are commonly exposed to this organism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8176682

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  7 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Serodetection of Ehrlichia canis infection in dogs from Ludhiana district of Punjab, India.

Authors:  L D Singla; Harkirat Singh; P Kaur; N D Singh; N K Singh; P D Juyal
Journal:  J Parasit Dis       Date:  2011-08-02

3.  Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis.

Authors:  S Harrus; T Waner; I Aizenberg; J E Foley; A M Poland; H Bark
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Serologic evidence for human ehrlichiosis in Africa.

Authors:  P Brouqui; C Le Cam; P J Kelly; R Laurens; A Tounkara; S Sawadogo; L Gondao; B Faugere; J Delmont
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

5.  Seroprevalence and Risk Factors of Ehrlichia canis Infection among Companion Dogs of Mashhad, North East of Iran, 2009-2010.

Authors:  Maneli Ansari-Mood; Javad Khoshnegah; Mehrdad Mohri; Seyed Mehdi Rajaei
Journal:  J Arthropod Borne Dis       Date:  2015-03-11       Impact factor: 1.198

6.  Ehrlichiosis, babesiosis, anaplasmosis and hepatozoonosis in dogs from St. Kitts, West Indies.

Authors:  Patrick J Kelly; Chuanling Xu; Helene Lucas; Amanda Loftis; Jamie Abete; Frank Zeoli; Audrey Stevens; Kirsten Jaegersen; Kate Ackerson; April Gessner; Bernhard Kaltenboeck; Chengming Wang
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

7.  Serodetection of Ehrlichia canis amongst dogs in central Namibia.

Authors:  Rutendo Manyarara; Ulf Tubbesing; Minty Soni; Bruce H Noden
Journal:  J S Afr Vet Assoc       Date:  2015-06-01       Impact factor: 1.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.